DP4CYCH4MT Uses, Dosage, Side Effects and more
DP4CYCH4MT is under investigation in clinical trial NCT02688101 (Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors).
| Trade Name | DP4CYCH4MT |
| Generic | Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone |
| Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone Other Names | DP4CYCH4MT |
| Type | |
| Formula | C19H23N5S |
| Weight | Average: 353.49 Monoisotopic: 353.167416935 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
